EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy

Allergy today is a public health concern of pandemic proportions, affecting more than 150 million people in Europe alone. In view of epidemiological trends, the European Academy of Allergy and Clinical Immunology (EAACI) predicts that within the next few decades, more than half of the European popul...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Calderon, Moises A, Demoly, Pascal, Gerth van Wijk, Roy, Bousquet, Jean, Sheikh, Aziz, Frew, Anthony, Scadding, Glenis, Bachert, Claus, Malling, Hans J, Valenta, Rudolph, Bilo, Beatrice, Nieto, Antonio, Akdis, Cezmi, Just, Jocelyne, Vidal, Carmen, Varga, Eva M, Alvarez-Cuesta, Emilio, Bohle, Barbara, Bufe, Albrecht, Canonica, Walter G, Cardona, Victoria, Dahl, Ronald, Didier, Alain, Durham, Stephen R, Eng, Peter, Fernandez-Rivas, Montserrat, Jacobsen, Lars, Jutel, Marek, Kleine-Tebbe, Jörg, Klimek, Ludger, Lötvall, Jan, Moreno, Carmen, Mosges, Ralph, Muraro, Antonella, Niggemann, Bodo, Pajno, Giovanni, Passalacqua, Giovanni, Pfaar, Oliver, Rak, Sabina, Senna, Gianenrico, Senti, Gabriela, Valovirta, Erkka, van Hage, Marianne, Virchow, Johannes C, Wahn, Ulrich, Papadopoulos, Nikolaos
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2012
נושאים:
Position Article and Guidelines
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3514324/
https://ncbi.nlm.nih.gov/pubmed/23110958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2045-7022-2-20
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים